Net profit of Zim Laboratories rose 10.00% to Rs 4.40 crore in the quarter ended December 2025 as against Rs 4.00 crore during the previous quarter ended December 2024. Sales rose 12.80% to Rs 108.66 crore in the quarter ended December 2025 as against Rs 96.33 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales108.6696.33 13 OPM %11.7912.01 - PBDT11.0810.58 5 PBT6.055.70 6 NP4.404.00 10 Powered by Capital Market - Live News

Zim Laboratories will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Zim Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 16 February 2026.Powered by Capital Market - Live News

Zim Laboratories will hold a meeting of the Board of Directors of the Company on 21 January 2026.Powered by Capital Market - Live News

Net loss of Zim Laboratories reported to Rs 0.42 crore in the quarter ended September 2025 as against net profit of Rs 2.38 crore during the previous quarter ended September 2024. Sales declined 3.72% to Rs 88.71 crore in the quarter ended September 2025 as against Rs 92.14 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales88.7192.14 -4 OPM %6.4910.34 - PBDT4.647.96 -42 PBT-0.342.96 PL NP-0.422.38 PL Powered by Capital Market - Live News